Medable launched an Agentic AI product designed to assist principal investigators in assessing electronic clinical outcome assessment (eCOA) data, automating reconciliation and highlighting items that require investigator review. The platform is goal‑oriented, governed by platform controls and retains human‑in‑the‑loop sign‑off to meet regulatory accountability needs. Medable framed the tool as a workload reducer for sites and sponsors handling large trials, with capabilities to plan, prioritize and present context‑aware summaries while preserving investigator responsibility for clinical decisions. The launch reflects growing uptake of regulated AI agents in trial operations to cut administrative burden and accelerate data review cycles.